BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10027482)

  • 21. Effects of acupuncture on smoking cessation or reduction for motivated smokers.
    He D; Berg JE; Høstmark AT
    Prev Med; 1997; 26(2):208-14. PubMed ID: 9085389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking cessation advice for patients with chronic periodontitis.
    Nasry HA; Preshaw PM; Stacey F; Heasman L; Swan M; Heasman PA
    Br Dent J; 2006 Mar; 200(5):272-5; discussion 265. PubMed ID: 16528334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
    Covey LS; Glassman AH; Jiang H; Fried J; Masmela J; LoDuca C; Petkova E; Rodriguez K
    Addiction; 2007 Aug; 102(8):1292-302. PubMed ID: 17624979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.
    Bozikas VP; Niopas I; Kafantari A; Kanaze FI; Gabrieli C; Melissidis P; Gamvrula K; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):1-6. PubMed ID: 15610938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of adolescent smokers with the nicotine patch.
    Hanson K; Allen S; Jensen S; Hatsukami D
    Nicotine Tob Res; 2003 Aug; 5(4):515-26. PubMed ID: 12959789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine for smoking cessation.
    Nana A; Praditsuwan R
    J Med Assoc Thai; 1998 Feb; 81(2):87-93. PubMed ID: 9529836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine lozenge efficacy in light smokers.
    Shiffman S
    Drug Alcohol Depend; 2005 Mar; 77(3):311-4. PubMed ID: 15734231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting.
    Fagerström KO; Hughes JR; Callas PW
    Nicotine Tob Res; 2002; 4 Suppl 2():S141-5. PubMed ID: 12573175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review.
    Fagerström KO; Hughes JR
    Nicotine Tob Res; 2002; 4 Suppl 2():S73-9. PubMed ID: 12573169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of the effects of hubble-bubble (Sheesha) and cigarette smoking on respiratory and metabolic parameters in hubble-bubble and cigarette smokers.
    Al Mutairi SS; Shihab-Eldeen AA; Mojiminiyi OA; Anwar AA
    Respirology; 2006 Jul; 11(4):449-55. PubMed ID: 16771915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nicotine polyestex gum on smoking cessation and quality of life.
    Rungruanghiranya S; Ekpanyaskul C; Hattapornsawan Y; Tundulawessa Y
    J Med Assoc Thai; 2008 Nov; 91(11):1656-62. PubMed ID: 19127785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine.
    Binnie V; McHugh S; Macpherson L; Borland B; Moir K; Malik K
    Oral Dis; 2004 Sep; 10(5):287-93. PubMed ID: 15315646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biomarkers of tobacco smoke exposure].
    Berny C; Boyer JC; Capolaghi B; De L'Homme G; Desch G; Garelik D; Hayder R; Houdret N; Jacob N; Koskas T; Lainé G; Le Moel G; Moulsma M; Plantin-Carrenard E; Venembre P
    Ann Biol Clin (Paris); 2002; 60(3):263-72. PubMed ID: 12050041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cranial electrostimulation therapy on short-term smoking cessation.
    Pickworth WB; Fant RV; Butschky MF; Goffman AL; Henningfield JE
    Biol Psychiatry; 1997 Jul; 42(2):116-21. PubMed ID: 9209728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cotinine effects on nicotine metabolism.
    Zevin S; Jacob P; Benowitz N
    Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.